Myopia Progression and the Effect of 7-Methylxanthine
NCT00263471
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Myopia
Interventions
DRUG:
7-methylxanthine
Sponsor
Trier Research Laboratories
Collaborators
[object Object]
[object Object]
[object Object]